When PD‐1, a surface signaling molecule in T cells, binds to the PD‐L1 or PD‐L2 receptors in neoplastic cells and within the tumor microenvironment, it inhibits T‐cell cytotoxicity against malignant cells.35 Here, PDCD1 is linked to neoplasm.